NextCure Inc. (NXTC)
NASDAQ: NXTC
· Real-Time Price · USD
4.93
-0.01 (-0.20%)
At close: Sep 08, 2025, 10:29 AM
-0.20% (1D)
| Bid | 3.76 |
| Market Cap | 13.19M |
| Revenue (ttm) | 3.28M |
| Net Income (ttm) | -60.93M |
| EPS (ttm) | -25.97 |
| PE Ratio (ttm) | -0.19 |
| Forward PE | -0.41 |
| Analyst | Buy |
| Ask | 6.14 |
| Volume | 2,103 |
| Avg. Volume (20D) | 120,943 |
| Open | 4.79 |
| Previous Close | 4.94 |
| Day's Range | 4.78 - 4.95 |
| 52-Week Range | 2.69 - 19.20 |
| Beta | 1.27 |
About NXTC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NXTC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NXTC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+1.15%
NextCure shares are trading higher after the compa...
Unlock content with
Pro Subscription
9 months ago
+1.55%
NextCure shares are trading higher after the company highlighted data demonstrating that NC605 resulted in enhanced generation of quality bone and better mechanical properties.
